Isomorphic Labs
isomorphiclabs.comOperator of a digital biology company intended to redefine drug discovery with the power of artificial intelligence.
Most Valuable
LBX PPS
1Y return
$46.29
Implied Valuation
$48.0B
+174.1% premium
Last Round
Jun 2026
$16.89
Series B · $17.5B
Price per share
12M · USD
Loading chart...
Funding history
$M raised · $B post-money
Loading chart...
Signals
1 latest
Isomorphic Labs in early talks to raise new funding at a valuation of at least $40B, possibly up to $50B, Bloomberg reports
Alphabet's AI drug-discovery company Isomorphic Labs is in early talks to raise new funds at a valuation of at least $40 billion, and the round could value it at as much as $50 billion, Bloomberg reported on 8 October 2026, citing people familiar with the matter. The financing has not closed and details could change. Isomorphic Labs did not respond to a request for comment. If completed, the round would set a new, higher valuation marker for the Google DeepMind spinout.
Source: Bloomberg
Explore related companies
More company profiles from the LBX Pro directory.